These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2653213)

  • 21. Purification and properties of a toxin isolated from Mortierella wolfii.
    Davey G; Smith JM; Kalmakoff J
    Infect Immun; 1973 Dec; 8(6):882-6. PubMed ID: 4784886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of yeast killer toxin in experimentally infected animals.
    Polonelli L; Conti S; Gerloni M; Campani L; Mantovani MP; Morace G
    Mycopathologia; 1990 Jun; 110(3):169-75. PubMed ID: 2201918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of killer toxin from a marine yeast Pichia anomala YF07b against the pathogenic yeast in crab.
    Wang X; Chi Z; Yue L; Li J
    Curr Microbiol; 2007 Nov; 55(5):396-401. PubMed ID: 17687604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marine killer yeasts active against a yeast strain pathogenic to crab Portunus trituberculatus.
    Wang L; Yue L; Chi Z; Wang X
    Dis Aquat Organ; 2008 Aug; 80(3):211-8. PubMed ID: 18814546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification by high performance liquid chromatography of Clostridium perfringens type A enterotoxin prepared from high toxin producers selected by a toxin-antitoxin halo.
    Sugimoto N; Ozutsumi K; Matsuda M
    Eur J Epidemiol; 1985 Jun; 1(2):131-8. PubMed ID: 2877901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the in vitro antimycotic activity of a novel killer protein from Williopsis saturnus DBVPG 4561 against emerging pathogenic yeasts.
    Buzzini P; Corazzi L; Turchetti B; Buratta M; Martini A
    FEMS Microbiol Lett; 2004 Sep; 238(2):359-65. PubMed ID: 15358421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.
    Buzzini P; Martini A
    Med Mycol; 2001 Dec; 39(6):479-82. PubMed ID: 11798052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer toxin of Pichia membranifaciens and its possible use as a biocontrol agent against grey mould disease of grapevine.
    Santos A; Marquina D
    Microbiology (Reading); 2004 Aug; 150(Pt 8):2527-2534. PubMed ID: 15289549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The primary and subunit structure of a novel type killer toxin produced by a halotolerant yeast, Pichia farinosa.
    Suzuki C; Nikkuni S
    J Biol Chem; 1994 Jan; 269(4):3041-6. PubMed ID: 8300637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the sensitivity of the yeast-like fungi Candida and Torulopsis to yeast producers of killer toxins].
    Budak A; Laskownicka Z; Wiercioch E
    Med Dosw Mikrobiol; 1985; 37(3-4):210-4. PubMed ID: 3831631
    [No Abstract]   [Full Text] [Related]  

  • 33. Purification and properties of Clostridium difficile cytotoxin B.
    Pothoulakis C; Barone LM; Ely R; Faris B; Clark ME; Franzblau C; LaMont JT
    J Biol Chem; 1986 Jan; 261(3):1316-21. PubMed ID: 3944088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris.
    Byrne MP; Titball RW; Holley J; Smith LA
    Protein Expr Purif; 2000 Apr; 18(3):327-37. PubMed ID: 10733887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of cereolysin and the electrophoretic separation of the active (reduced) and inactive (oxidized) forms of the purified toxin.
    Cowell JL; Grushoff-Kosyk PS; Bernheimer AW
    Infect Immun; 1976 Jul; 14(1):144-54. PubMed ID: 820638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoprotective activity of mannoprotein from the cell membrane of Pichia anomala.
    Kawahara H; Omori N; Obata H
    Cryo Letters; 2008; 29(5):437-45. PubMed ID: 18946558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Killer system: a simple method for differentiating Candida albicans strains.
    Polonelli L; Archibusacci C; Sestito M; Morace G
    J Clin Microbiol; 1983 May; 17(5):774-80. PubMed ID: 6345575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii.
    Hodgson VJ; Button D; Walker GM
    Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():2003-2012. PubMed ID: 7551063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yeast killer toxin-like anti-idiotypic antibodies.
    Polonelli L; Morace G
    J Clin Microbiol; 1988 Mar; 26(3):602-4. PubMed ID: 2451680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.